Literature DB >> 32315808

The relative transmissibility of asymptomatic COVID-19 infections among close contacts.

Daihai He1, Shi Zhao2, Qianying Lin3, Zian Zhuang4, Peihua Cao5, Maggie H Wang2, Lin Yang6.   

Abstract

Asymptomatic transmission of the coronavirus disease 2019 is an important topic. A recent study in China showed that transmissibility of the asymptomatic cases is comparable to that of symptomatic cases. Here, we discuss that the conclusion may depend on how we interpret the data. To the best of our knowledge, this is the first time the relative transmissibility of asymptomatic COVID-19 infections is quantified.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Asymptomatic infection; COVID-19; Relative transmissibility

Mesh:

Year:  2020        PMID: 32315808      PMCID: PMC7166025          DOI: 10.1016/j.ijid.2020.04.034

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


Nishiura et al. (2020) estimated the asymptomatic ratio of COVID-19 was 41.6% (5 out of 12 confirmed cases) among 565 Japanese individuals evacuated from Wuhan, China. Mao et al. (2020) reported that 2 out of 78 confirmed cases are asymptomatic. One of the two cases showed RT-PCT positivity 15th days after first diagnosis. Mizumoto et al. (2020) estimated that the 17.9% of cases on the Diamond Princess Cruise Ship were asymptomatic case during the outbreak in February 2020. However, the transmissibility of asymptomatic case is unclear, and the positive RT-PCT results only imply the potential infectivity. It is important to study the patterns of viral shedding and live virus isolation. Wölfel et al. (2020) studied 9 hospitalized cases and found that live virus was isolated from throat and lung-derived samples up to 8 days after symptom onset. When the RNA concentration is above 106 copies per ml (or equivalent Ct-value lower than 24), but not from stool samples, despite of high virus RNA concentration. Above the threshold, high RNA concentration yields high probability of live virus isolation. This ‘dose-response’ association highlights a patient's RT-PCR level should be higher than a threshold to be effectively infectious. Zou et al. (2020) monitored the viral shedding for 18 patients including 3 severe cases, 14 mild to moderate cases and 1 asymptomatic case. It was found that the viral shedding pattern of COVID-19 patients resembles that of influenza patients rather than that of SARS patients. The patterns of virus shedding in Zou et al. (2020) and Wölfel et al. (2020) are similar. These results explained the shorter serial interval and incubation period of COVID than that of SARS patients (Guan et al., 2020, Du et al., 2020). As of April 4, 2020, 150 asymptomatic cases were reported in Hong Kong out of 915 confirmed cases, giving a crude ratio of 16.4%. The weekly asymptomatic ratio showed interesting pattern in Figure 1 . In Hong Kong, asymptomatic cases are most likely from young imported cases, and in recent months, Hong Kong are facing a large number of relatively young imported cases.
Figure 1

Weekly asymptomatic case ratio (out of weekly confirmed cases) in Hong Kong. Cases are grouped in weeks according to the laboratory confirmation date.

Weekly asymptomatic case ratio (out of weekly confirmed cases) in Hong Kong. Cases are grouped in weeks according to the laboratory confirmation date. The asymptomatic transmission of the COVID-19 is an important topic in understanding the transmissivity of COVID-19 (Qiu, 2020). To our knowledge, the transmissibility of asymptomatic cases has not been quantified. In a recent paper, Chen et al. (2020) investigated the transmissibility of asymptomatic cases among close contacts, and claimed no statistical difference between the transmissibility of asymptomatic cases versus that of symptomatic cases. In this work, we re-analysed their dataset, and argue that the transmissibility of asymptomatic cases could be lower than that of the symptomatic case by comparing the reproduction numbers. According to the COVID-19 surveillance data in Chen et al. (2020), the first generation consist 161 symptomatic cases and 30 asymptomatic cases in Ningbo, China from Jan 20 to March 6, 2020. The symptomatic and asymptomatic groups have 2001 and 146 close contacts, respectively. The consecutive secondary infections consist 110 symptomatic cases and 22 asymptomatic cases, see Table 1 . According to Chen et al. (2020), the number of cases per contacts is calculated as (126/2001 =) 0.063 and (6/146 =) 0.041 for the symptomatic and asymptomatic groups respectively, and then concluded that the difference among the transmissibility of the two groups was not statistically significant.
Table 1

Summary of the COVID-19 transmission and contact tracing in Ningbo from January 21 to March 6, 2020. The data are obtained from Chen et al. (2020).

First generationClose contactsSecond generation
SymptomaticAsymptomaticSub-total
Symptomatic161200110719126
Asymptomatic30146336
Total191214711022132
Summary of the COVID-19 transmission and contact tracing in Ningbo from January 21 to March 6, 2020. The data are obtained from Chen et al. (2020). Theoretically, the transmissibility (of an infectious disease) can be quantified by the reproduction number (R). The R is defined the ratio of the case counts in the first generation divided by those in the second generation, namely the number of secondary cases per index case, and thus it is proportional to the risk of infection, i.e., force of infection. Hence, by definition, the Rs can be calculated as (126/161 =) 0.78 and (6/30 =) 0.20 for the symptomatic and asymptomatic groups respectively. Therefore, the risk ratio (RR) of infectivity of a symptomatic group against that of the asymptomatic group is estimated at 3.9 (95%CI: 1.5–11.8). If focusing on symptomatic secondary infections, the RR is estimated at 6.6 (95%CI: 2.0–34.7). In the classic ‘SEIR’ modelling framework, the basic reproduction number, R 0  =  β   γ −1  =  ρθ   γ −1. Here, the γ −1 is the mean infectious period and the β is effective contact rate. The β can be formulated as β  =  ρθ, where θ is the average contact rate (common unit: contact per day) and the ρ is the risk (probability) of transmission per contact. Thus, the RR of the ρ of symptomatic group against the ρ of the asymptomatic group is estimated at [(126/2001]/(6/146)=] 1.5 (95%CI: 0.7–3.4). This indicates the symptomatic cases are likely to be more infectious than the asymptomatic cases though this difference is statistically insignificant. However, the mean infectious period (γ −1) of a symptomatic case may be longer than that of an asymptomatic case hypothetically. Therefore, the combined effects of ρ and γ −1 probably lead to a higher reproduction number in the symptomatic group. Additionally, Chen et al. (2020) showed that asymptomatic cases are more likely to produce asymptomatic cases relatively speaking, since the 6 secondary cases from asymptomatic primary cases consist 3 asymptomatic cases (50%). Whereas 19 out of 126 (15%) are asymptomatic from symptomatic primary cases. The odds ratio (OR) is estimated at 5.5 (95%CI: 0.7–44.4). We note that such a phenomenon may as well have occurred in the COVID-19 outbreak on the Diamond Princess cruise ship in February 2020 (Zhao et al., 2020), where a large proportion of asymptomatic cases were confirmed in the last 10 days of the quarantine period. Namely, asymptomatic COVID-19 cases may likely produce asymptomatic offspring. This study contains limitation. Our analysis is conducted based on the contact tracing surveillance data. Referring to Table 1, the close contacts per primary case of the symptomatic group are [(2001/161)/(146/30)−1=] 1.6-fold (95%CI: 0.8–2.6) more than those of the asymptomatic group. On the one hand, the difference could be merely due to the difference in the contact pattern as pointed out (Chen et al., 2020), which would not affect our main results. On the other hand, this difference in the contact tracing might partially be due to the difference in the contact tracing surveillance scheme implemented on the two groups of the primary cases. In such case, the RR estimate may be higher than its true value. Cautious should be taken in interpreting these data, and understanding this gap would improve our conclusions. In summary, we conclude that the relatively transmissibility of asymptomatic case could be significantly smaller than that of the symptomatic cases. The main contribution of Chen et al. (2020) is that they raise the alarm of the existence of the transmissibility of the asymptomatic cases. We remark that how efficient of the transmissibility of asymptomatic cases comparing to symptomatic cases warrants more study.

Declarations

Ethics approval and consent to participate

The ethical approval or individual consent was not applicable.

Availability of data and materials

All data and materials used in this work were publicly available.

Consent for publication

Not applicable.

Conflict of interest statement

DH was supported by an Alibaba (China) – Hong Kong Polytechnic University Collaborative Research project. Other authors declared no competing interests.

Funding statement

DH was supported by General Research Fund (15205119) of Research Grants Council of Hong Kong and an Alibaba (China) – Hong Kong Polytechnic University Collaborative Research project (P0031768). The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.
  7 in total

1.  Covert coronavirus infections could be seeding new outbreaks.

Authors:  Jane Qiu
Journal:  Nature       Date:  2020-03-20       Impact factor: 49.962

2.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

3.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.

Authors:  Lirong Zou; Feng Ruan; Mingxing Huang; Lijun Liang; Huitao Huang; Zhongsi Hong; Jianxiang Yu; Min Kang; Yingchao Song; Jinyu Xia; Qianfang Guo; Tie Song; Jianfeng He; Hui-Ling Yen; Malik Peiris; Jie Wu
Journal:  N Engl J Med       Date:  2020-02-19       Impact factor: 91.245

4.  Evidence from two cases of asymptomatic infection with SARS-CoV-2: Are 14 days of isolation sufficient?

Authors:  Ren Wan; Zhi-Qun Mao; Li-Yi He; Yue-Chun Hu
Journal:  Int J Infect Dis       Date:  2020-04-03       Impact factor: 3.623

5.  Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.

Authors:  Zhanwei Du; Xiaoke Xu; Ye Wu; Lin Wang; Benjamin J Cowling; Lauren Ancel Meyers
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

6.  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).

Authors:  Hiroshi Nishiura; Tetsuro Kobayashi; Takeshi Miyama; Ayako Suzuki; Sung-Mok Jung; Katsuma Hayashi; Ryo Kinoshita; Yichi Yang; Baoyin Yuan; Andrei R Akhmetzhanov; Natalie M Linton
Journal:  Int J Infect Dis       Date:  2020-03-14       Impact factor: 3.623

7.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.

Authors:  Kenji Mizumoto; Katsushi Kagaya; Alexander Zarebski; Gerardo Chowell
Journal:  Euro Surveill       Date:  2020-03
  7 in total
  74 in total

1.  EpiBeds: Data informed modelling of the COVID-19 hospital burden in England.

Authors:  Christopher E Overton; Lorenzo Pellis; Helena B Stage; Francesca Scarabel; Joshua Burton; Christophe Fraser; Ian Hall; Thomas A House; Chris Jewell; Anel Nurtay; Filippo Pagani; Katrina A Lythgoe
Journal:  PLoS Comput Biol       Date:  2022-09-06       Impact factor: 4.779

2.  Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients.

Authors:  Saadia Omer; Mehrunnisa Fatima Gondal; Muhammad Usman; Muhammad Bilal Sarwar; Muhammad Roman; Alam Khan; Nadeem Afzal; Tanveer Ahmed Qaiser; Muhammad Yasir; Faheem Shahzad; Romeeza Tahir; Saima Ayub; Javed Akram; Raja Muhammad Faizan; Muhammad Asif Naveed; Shah Jahan
Journal:  Front Cell Infect Microbiol       Date:  2022-05-26       Impact factor: 6.073

Review 3.  Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic.

Authors:  Yutong Wang; Ke Zheng; Wenjing Gao; Jun Lv; Canqing Yu; Lan Wang; Zijun Wang; Bo Wang; Chunxiao Liao; Liming Li
Journal:  Med Rev (Berl)       Date:  2022-02-24

4.  Implementation of a COVID-19 Infection Control Plan in a Large Urban Jail System.

Authors:  Nazia Qureshi; Charles Cardenas; Ngoc Dung Tran; Sean O Henderson
Journal:  Public Health Rep       Date:  2022-02-21       Impact factor: 3.117

Review 5.  COVID-19 Pandemic: The Influence of Culture and Lessons for Collaborative Activities.

Authors:  Linda Simon Paulo; George M Bwire; Xingchen Pan; Tianyue Gao; Amene Saghazadeh; Chungen Pan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19.

Authors:  Florence Fenollar; Amar Bouam; Mehdi Ballouche; Léa Fuster; Elsa Prudent; Philippe Colson; Hervé Tissot-Dupont; Matthieu Million; Michel Drancourt; Didier Raoult; Pierre-Edouard Fournier
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

7.  Modelling personal cautiousness during the COVID-19 pandemic: a case study for Turkey and Italy.

Authors:  Hatice Bulut; Meltem Gölgeli; Fatihcan M Atay
Journal:  Nonlinear Dyn       Date:  2021-05-11       Impact factor: 5.022

8.  Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around them.

Authors:  Franck de Laval; Anaïs Grosset-Janin; François Delon; Alexandre Allonneau; Christelle Tong; Flavie Letois; Anne Couderc; Marc-Antoine Sanchez; César Destanque; Fabrice Biot; Françoise Raynaud; Christine Bigaillon; Olivier Ferraris; Etienne Simon-Loriere; Vincent Enouf; Dinaherisoa Andriamanantena; Vincent Pommier de Santi; Emilie Javelle; Audrey Mérens
Journal:  BMC Infect Dis       Date:  2021-05-19       Impact factor: 3.090

9.  Exploring secondary SARS-CoV-2 transmission from asymptomatic cases using contact tracing data.

Authors:  Ko Nakajo; Hiroshi Nishiura
Journal:  Theor Biol Med Model       Date:  2021-07-16       Impact factor: 2.432

10.  Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example.

Authors:  Chunyu Li; Yuchen Zhu; Chang Qi; Lili Liu; Dandan Zhang; Xu Wang; Kaili She; Yan Jia; Tingxuan Liu; Daihai He; Momiao Xiong; Xiujun Li
Journal:  Front Med (Lausanne)       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.